Laboratory of America Holdings (LH)

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US50540R4092

Laboratory Corporation of America Holdings, trading under NYSE symbol LH, functions as a leading life sciences corporation that plays a crucial role in assisting medical professionals, hospitals, pharmaceutical firms, researchers, and patients in making well-informed decisions. The company operates through two key segments, namely Labcorp Diagnostics and Labcorp Drug Development.

Labcorp offers a wide range of tests including blood chemistry analyses, urinalyses, thyroid tests, PAP tests, vitamin D assessments, tests for sexually transmitted diseases, microbiology cultures, hepatitis C screenings, among many others. Additionally, they specialize in gene-based testing, esoteric testing, and disease-specific evaluations encompassing areas such as oncology, cardiology, genetics, infectious diseases, and women's health.

Moreover, Labcorp provides a variety of health and wellness services to employers and managed care organizations, including health fairs, on-site testing, vaccinations, and health screenings. The company also offers online and mobile applications for patients to access their test results conveniently and efficiently.

Furthermore, Labcorp delivers end-to-end solutions in drug development, medical device pioneering, and companion diagnostic development, catering to early-stage research through clinical development and commercial market access. Their clientele includes managed care organizations, pharmaceutical companies, medical device manufacturers, healthcare providers, employers, patients, and clinical laboratories.

Established in 1994, Labcorp's headquarters are located in Burlington, North Carolina. For more information, visit their website at https://www.labcorp.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Laboratory of America Holdings (LH)

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Laboratory of America Holdings (LH)

LH Stock Overview

Market Cap in USD 17,935m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 1990-03-29

LH Stock Ratings

Fundamental 1.64
Dividend 1.87
Growth 5y 4.78
Rel. Performance vs Sector -0.15
Analysts 4.06/5
Fair Price Momentum 200.15 USD
Fair Price DCF 279.99 USD

LH Dividends

Yield 12m 1.28%
Yield on Cost 5y 2.14%
Dividends CAGR 5y 4.02%
Payout Consistency 7.4%

LH Growth Ratios

Growth 12m 15.18%
Growth Correlation 12m 53%
Growth Correlation 3m -64%
CAGR 5y 10.78%
Sharpe Ratio 12m 0.56
Alpha vs SP500 12m -16.21
Beta vs SP500 5y weekly 0.97
ValueRay RSI 57.77
Volatility GJR Garch 1y 20.91%
Price / SMA 50 -1.03%
Price / SMA 200 2.32%
Current Volume 430.7k
Average Volume 20d 787.2k

External Links for LH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of LH stocks?
As of March 29, 2024, the stock is trading at USD 216.57 with a total of 430,701 shares traded.
Over the past week, the price has changed by +3.44%, over one month by +0.41%, over three months by -4.14% and over the past year by +16.25%.
What is the forecast for LH stock price target?
According to ValueRays Forecast Model, LH Laboratory of America Holdings will be worth about 219.8 in March 2025. The stock is currently trading at 216.57. This means that the stock has a potential upside of +1.51%.
Issuer Forecast Upside
Wallstreet Target Price 246.8 14.0%
Analysts Target Price 244.1 12.7%
ValueRay Target Price 219.8 1.51%